Lidocaine Accord (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the influx of sodium ions that is required for the generation and propagation of action potentials. This inhibition stops nerve impulses from reaching the brain, producing a reversible loss of sensation in the area where it is applied.

The appropriate dose of Lidocaine Accord is determined by the prescribing clinician based on the specific procedure, route of administration, patient age, weight, and clinical condition. Healthcare professionals calculate the dose to achieve effective anesthesia while minimizing the risk of systemic toxicity.

The safety of Lidocaine Accord in pregnancy and lactation has not been definitively established, and it is classified as pregnancy category unknown. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To request Lidocaine Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for many short‑procedural applications. Compared with agents such as bupivacaine, lidocaine has a shorter half‑life and lower risk of prolonged cardiotoxicity, though it may require repeat dosing for longer procedures.

Lidocaine Accord should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the solution, and inspect the container for any signs of damage before use.

Lidocaine Accord is administered by a qualified healthcare professional via epidural, intramuscular, or intravenous injection, depending on the clinical indication. The injection site, volume, and rate are selected to achieve the desired anesthetic effect while monitoring the patient for any adverse reactions.

Serious risks include systemic toxicity leading to seizures, cardiac arrhythmias, respiratory depression, and rare cases of methemoglobinemia or severe allergic reactions. Prompt recognition of symptoms and immediate medical intervention are essential to mitigate these potentially life‑threatening events.

Lidocaine Accord should be avoided in individuals with known hypersensitivity to lidocaine or other amide‑type local anesthetics, patients with severe hepatic impairment, and those with certain cardiac conduction disorders unless specifically directed by a physician. Use in pediatric or geriatric patients requires careful dose adjustment.